Alpine Global Management LLC Raises Position in Liquidia Co. (NASDAQ:LQDA)

Alpine Global Management LLC raised its holdings in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) by 50.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 150,000 shares of the company's stock after purchasing an additional 50,000 shares during the quarter. Alpine Global Management LLC owned 0.18% of Liquidia worth $1,764,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in LQDA. Vanguard Group Inc. raised its stake in Liquidia by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 3,557,296 shares of the company's stock valued at $41,834,000 after acquiring an additional 115,367 shares during the period. LM Advisors LLC purchased a new stake in Liquidia in the fourth quarter worth about $25,948,000. Whitefort Capital Management LP boosted its position in shares of Liquidia by 16.8% during the fourth quarter. Whitefort Capital Management LP now owns 1,987,245 shares of the company's stock valued at $23,370,000 after purchasing an additional 285,220 shares in the last quarter. Vestal Point Capital LP boosted its position in shares of Liquidia by 17.3% in the 4th quarter. Vestal Point Capital LP now owns 1,760,000 shares of the company's stock worth $20,698,000 after purchasing an additional 260,000 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in Liquidia by 8.2% in the fourth quarter. Geode Capital Management LLC now owns 1,339,254 shares of the company's stock worth $15,753,000 after buying an additional 101,597 shares during the last quarter. Institutional investors own 64.54% of the company's stock.

Analysts Set New Price Targets

A number of research firms have weighed in on LQDA. Raymond James increased their target price on Liquidia from $27.00 to $29.00 and gave the company a "strong-buy" rating in a report on Friday, May 9th. Oppenheimer set a $13.00 price target on shares of Liquidia and gave the stock an "underperform" rating in a research report on Monday, May 19th. Scotiabank boosted their price objective on Liquidia from $36.00 to $37.00 and gave the company a "sector outperform" rating in a report on Wednesday. HC Wainwright increased their price objective on Liquidia from $29.00 to $35.00 and gave the stock a "buy" rating in a research note on Wednesday. Finally, Wall Street Zen upgraded shares of Liquidia from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $26.67.

Liquidia Stock Down 6.7%

NASDAQ:LQDA traded down $1.05 during trading hours on Wednesday, reaching $14.56. 816,019 shares of the stock were exchanged, compared to its average volume of 1,072,878. Liquidia Co. has a twelve month low of $8.26 and a twelve month high of $19.41. The business has a 50-day moving average of $14.76 and a two-hundred day moving average of $13.65. The company has a market capitalization of $1.24 billion, a price-to-earnings ratio of -8.93 and a beta of 0.24.

Liquidia (NASDAQ:LQDA - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). The firm had revenue of $3.12 million for the quarter, compared to analysts' expectations of $3.23 million. Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. On average, research analysts forecast that Liquidia Co. will post -1.51 EPS for the current fiscal year.

Insider Activity at Liquidia

In other news, CEO Roger Jeffs sold 14,130 shares of the firm's stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $13.57, for a total transaction of $191,744.10. Following the transaction, the chief executive officer now directly owns 1,006,420 shares in the company, valued at approximately $13,657,119.40. This trade represents a 1.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Jason Adair sold 1,856 shares of the stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $25,185.92. Following the sale, the insider now owns 184,304 shares of the company's stock, valued at $2,501,005.28. This trade represents a 1.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,138 shares of company stock valued at $450,233 over the last 90 days. 26.50% of the stock is owned by corporate insiders.

Liquidia Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).